Clinical Trial Update: A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports on the long-term safety of repeated QUTENZA administration for pain due to nerve damage in diabetic patients, with th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Peripheral Neuropathy

Drugs mentioned

• QUTENZA (Capsaicin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Painful Diabetic Peripheral Neuropathy (PDPN) | Phase 3 | Status: COMPLETED